Rocket Lab Secures Strategic War Chest Amid Neutron Delay

Rocket Lab secures major capital, acquires Mynaric, and sees analyst upgrade despite Neutron rocket delay. Shares rise over 5%.

Rocket Lab USA has fortified its balance sheet with a capital raise potentially exceeding one billion dollars, providing a robust financial runway as it navigates a key rocket development delay and executes a strategic acquisition. The market responded favorably, with one analyst upgrading the stock and shares climbing over 5%.

The company concluded an at-the-market offering, selling approximately 6.7 million shares to raise $474 million in gross proceeds. In a parallel move, it entered into collared forward transactions covering an additional 7.45 million shares. This structure guarantees minimum proceeds of another $474 million, with an upside potential reaching $642 million depending on the stock price at settlement in April 2028. Combined with the $829 million in liquid resources reported at the end of 2025, this creates a substantial financial foundation for Rocket Lab's ambitious plans.

A primary use for the fresh capital is the pending acquisition of German laser communications specialist Mynaric. Regulatory approval from German authorities was secured in late March, with the transaction expected to close this April. Mynaric's optical inter-satellite link technology is considered a critical component for fulfilling existing contracts with the U.S. Space Development Agency (SDA), which are valued at $1.3 billion.

The company's operational momentum is underscored by a growing order backlog, which recently surged 69% to $1.85 billion. This portfolio includes an $816 million SDA contract for satellite construction and a separate $190 million award for hypersonic testing. Analysts project the company's revenue could reach approximately $880 million in 2026, with a path to profitability potentially opening in early 2027.

This financial and operational strength prompted analysts at Citizens to upgrade Rocket Lab's stock to "Market Outperform" on Tuesday, assigning an $85 price target. Investors followed suit, pushing the share price up roughly 5.5% to $69.94 by Wednesday afternoon.

However, a significant development hurdle remains. The maiden launch of Rocket Lab's new medium-lift Neutron rocket, capable of carrying over 15 tons to orbit, has been postponed to the fourth quarter of 2026. This delay shifts immediate investor focus to the company's upcoming quarterly results on May 7th. For that period, experts anticipate a sharp revenue jump to around $191 million, compared to just under $123 million in the prior-year quarter.